<DOC>
	<DOCNO>NCT01574339</DOCNO>
	<brief_summary>The EndoStim LES Stimulation System investigational device intend improve LES pressure restore Lower Esophageal Sphincter ( LES ) function individual suffer Gastroesophageal Reflux Disease ( GERD ) .</brief_summary>
	<brief_title>Effect Long-Term Electrical Stimulation LES Pressure Esophageal Acid Exposure Patients With GERD</brief_title>
	<detailed_description>EndoStim develop investigational medical device specifically design deliver electrical stimulation LES complete two clinical feasibility study use external version EndoStim stimulation system fifteen subject . In two short-term study , electrical stimulation result significant increase LES pressure . This study evaluate safety procedure feasibility use group patient .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Subject 21 70 year age . Subject history heartburn , regurgitation &gt; 12 month prompt physician recommendation continual daily use PPI study entry . Baseline GERD HRQL heartburn score follow 1014 day PPI ≥ 20 least 10 point higher PPI score Subject standard medical therapy 12 month long experience discomfort otherwise dissatisfied GERD symptom Subjects GERD condition opinion PI justifies minimally invasive reversible procedure prior attempt anatomical change Nissen fundoplication Subject American Society Anesthesiologists ( ASA ) Physical Status Classification I II ( comparable local classification ) . Subject exhibit excessive low esophageal acid exposure 24hour pHmetry antisecretory therapy perform within 6 month screen visit ; pH &lt; 4 &gt; 5 % total time . Subject rest LES end expiratory pressure &gt; 5mm Hg &lt; 15 mm Hg high resolution manometry within 6 month enrollment . Subject esophagitis ≤ Grade C ( LA classification ) upper endoscopy within 6 month enrollment . Subject esophageal body contraction amplitude &gt; 30 mmHg &gt; 50 % swallow &gt; 50 % peristaltic contraction high resolution manometry . Subject sign informed consent form able adhere study visit schedule . Subject nonGERD esophageal motility disorder . Subject gastroparesis . Subject significant multisystem disease . Subject autoimmune connective tissue disorder ( e.g . scleroderma , dermatomyositis , CalcinosisRaynaud'sEsophagus , Sclerodactyly Syndrome ( CREST ) , Sjogren 's Syndrome , Sharp 's Syndrome ) , require therapy precede 2 year . Subject Barrett 's epithelium ( &gt; M2 ; &gt; C1 ) grade dysplasia . Subject hiatal hernia large 3 cm . Subject body mass index ( BMI ) great 35 kg/m2 . Subject Type 1 diabetes mellitus Subject uncontrolled Type 2 diabetes mellitus ( T2DM ) define HbA1c &gt; 9.5 previous 6 month , T2DM &gt; 10 year . Subject history suspect confirmed esophageal gastric cancer . Subject esophageal gastric varix . Subject significant cardiac arrhythmia ectopy significant cardiovascular disease . Subject exist implanted electrical stimulator ( e.g. , pacemaker , AICD ) . Subject require chronic anticoagulant therapy . Subject dysphagia esophageal peptic stricture , exclude Schatzki 's ring . Subject childbearing potential pregnant intend become pregnant trial period . Subject currently enrol potentially confound research . History malignancy last 2 year . History previous esophageal gastric surgery , include nissen fundoplication . Subject condition , discretion investigator sponsor , would preclude participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>GERD</keyword>
	<keyword>LES Pressure</keyword>
	<keyword>Electrical Stimulation</keyword>
</DOC>